PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
14.32%
Net income growth of 14.32% while TSM is zero at 0.00%. Bruce Berkowitz would see a modest advantage that can compound if well-managed.
-13.07%
Negative yoy D&A while TSM is 0.00%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
99.71%
Deferred tax of 99.71% while TSM is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
-142.86%
Negative yoy SBC while TSM is 0.00%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
-76.34%
Negative yoy working capital usage while TSM is 0.00%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
90.15%
AR growth of 90.15% while TSM is zero at 0.00%. Bruce Berkowitz would see a mild difference in credit approach that could matter for cash flow.
56.90%
Inventory growth of 56.90% while TSM is zero at 0.00%. Bruce Berkowitz would see a moderate build that must match future sales to avoid risk.
-116.69%
Negative yoy AP while TSM is 0.00%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
138.39%
Growth of 138.39% while TSM is zero at 0.00%. Bruce Berkowitz would see a difference in minor WC usage that might affect short-term cash flow if large.
-77.09%
Negative yoy while TSM is 0.00%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
2.58%
CFO growth of 2.58% while TSM is zero at 0.00%. Bruce Berkowitz would see a modest edge that could widen if cost discipline remains strong.
74.85%
CapEx growth of 74.85% while TSM is zero at 0.00%. Bruce Berkowitz would see a mild cost burden that must yield returns in future revenue or margins.
-106.21%
Negative yoy acquisition while TSM stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
27.20%
Purchases growth of 27.20% while TSM is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
226.86%
Liquidation growth of 226.86% while TSM is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
-8060.00%
We reduce yoy other investing while TSM is 0.00%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
44.85%
We expand invests by 44.85% while TSM is zero at 0.00%. Bruce Berkowitz sees a moderate outflow that must be justified by returns vs. competitor’s stable approach.
No Data
No Data available this quarter, please select a different quarter.
-69.47%
Negative yoy issuance while TSM is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
No Data
No Data available this quarter, please select a different quarter.